Meeder Advisory Services Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,424 shares of the healthcare conglomerate's stock after purchasing an additional 1,420 shares during the period. UnitedHealth Group accounts for 0.6% of Meeder Advisory Services Inc.'s portfolio, making the stock its 29th largest holding. Meeder Advisory Services Inc.'s holdings in UnitedHealth Group were worth $9,603,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Delta Financial Group Inc. boosted its position in UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate's stock valued at $965,000 after buying an additional 17 shares during the period. Signature Resources Capital Management LLC lifted its holdings in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 18 shares during the period. Saxony Capital Management LLC increased its stake in shares of UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate's stock valued at $270,000 after buying an additional 18 shares during the period. GoalVest Advisory LLC boosted its holdings in UnitedHealth Group by 0.6% in the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate's stock valued at $1,591,000 after acquiring an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC raised its holdings in UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate's stock worth $1,882,000 after purchasing an additional 18 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Stock Performance
UNH stock traded down $2.58 on Monday, hitting $589.65. The company had a trading volume of 2,576,785 shares, compared to its average volume of 3,883,119. The stock's 50-day simple moving average is $582.84 and its 200 day simple moving average is $549.98. The stock has a market cap of $542.64 billion, a price-to-earnings ratio of 38.29, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. During the same period last year, the firm posted $6.56 earnings per share. The business's revenue for the quarter was up 9.2% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group's dividend payout ratio is currently 54.72%.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on UNH shares. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a research report on Wednesday, October 16th. Stephens lowered their target price on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating for the company in a research note on Wednesday, October 16th. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a report on Wednesday, October 16th. UBS Group reduced their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Finally, Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $615.53.
View Our Latest Report on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.